UNSPSC 51412007: Ipramidil

This classification denotes a vasodilating agent with the molecular formula C10H16N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9ZPC9768EH, chemically known as n,n-diisopropyl-3,4-furazandicarboxamide 2-oxide but generally known as ipramidil, which bears US NIH Compound Identifier 71268. European Medicines Agency schedules Ipramidil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08275MIG.

UNSPSC 51412007 Ipramidil is a Commodity code for a specific pharmaceutical product, but the recent state and local procurement activity under this code does not align with the code's nominal scope. The City of Tampa's Purchasing Department posted an IFB (Bid No. 26P00188) on April 24, 2026, soliciting Advanced Life Support Medications for Tampa Fire Rescue, but the bid requests Labetalol HCI, Epinephrine, Adenosine, and Diltiazem — none of which is Ipramidil. State and local governments use this code inconsistently; the Tampa solicitation appears to be a coding error rather than a representation of actual Ipramidil procurement. The scope of the Tampa bid itself covers emergency medical pharmaceuticals supplied in vial and injection form, with strict expiration-date and warranty requirements, delivery within ten calendar days, and pickup/replacement obligations before product expiration.

The City of Tampa is the only recent issuer identified for this code. The solicitation shows activity in Florida (Hillsborough County) with an estimated contract value of $40,000 and a one-year initial term plus renewal options. The IFB response date was April 8, 2026, now closed. The bid included a Small Local Business Enterprise (SLBE) sheltered market designation with a 5 percent discount capped at $10,000, required Safety Data Sheets compliant with OSHA Hazard Communication Standards, and comprehensive accessibility documentation per WCAG 2.2 Level AA and Section 508. Given the code mismatch and the sparse recent-opportunity record, pursuit under this specific commodity code is not recommended without direct confirmation from a potential issuer that Ipramidil itself is being procured.